Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03174782 · ClinicalTrials.gov registry record · Phase 4
Peripheral Nerve Blocks for Major Lower Extremity Amputations
A Phase 4 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
NCT03174782 is a Phase 4 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 42 participants.
The verdict
NCT03174782, a Phase 4 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study will be a double-blinded randomized controlled trial analyzing all patients who will undergo major lower extremity amputations by the vascular surgery service at University of California, San Francisco (UCSF) Fresno between July 2017 and June 2018 to determine if regional nerve blocks (sciatic and femoral) have any effect on postoperative pain control, narcotic requirements, and length of stay compared with standard post-operative narcotic regimens.
Interventions
- DRUG Bupivacaine
- DRUG Saline Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2021-04-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03174782
The ClinicalTrials.gov registry entry for NCT03174782 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03174782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03174782 about?
NCT03174782 is a clinical study titled "Peripheral Nerve Blocks for Major Lower Extremity Amputations". This study will be a double-blinded randomized controlled trial analyzing all patients who will undergo major lower extremity amputations by the vascular surgery service at University of California, San Francisco (UCSF) Fresno between July 2017 and June 2018 to determine if regional nerve blocks (sc...
What is the current status of trial NCT03174782?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2018-01-01. Estimated completion is 2021-04-27.
What interventions are being tested in trial NCT03174782?
The interventions under investigation include: Bupivacaine (DRUG), Saline Solution (DRUG).
Who is sponsoring clinical trial NCT03174782?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.